Ertapenem resistance in 2 tertiary-care hospitals: Microbiology, epidemiology, and risk factors;Resistencia a ertapenem en 2 instituciones hospitalarias de alto nivel de complejidad: microbiología, epidemiología y factores de riesgo

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 35, Issue 8, 2017, Pages 511-515

  Maldonado, Natalia ^a   Castro, Bibiana ^b   Berrio, Indira ^c   Manjarrés, Miguel ^c   Robledo, Carlos ^a,c   Robledo, Jaime ^a,c,d  

^a Laboratorio Médico de Referencia   (Colombia)

^b UNIVERSIDAD CES   (Colombia)

^c Clinic el Rosario   (Colombia)

^d UNIVERSIDAD PONTIFICIA BOLIVARIANA   (Colombia)

Author keywords

Carbapenem resistance; Carbapenems; Enterobacteriaceae infections; Risk factors

Indexed keywords

CEFEPIME; ERTAPENEM; CARBAPENEM DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ERTAPENEM RESISTANT ENTEROBACTERIACEAE; HUMAN; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; RISK FACTOR; TERTIARY CARE CENTER; AGED; ANTIMICROBIAL STEWARDSHIP; BETA-LACTAM RESISTANCE; CASE CONTROL STUDY; CLINICAL TRIAL; COLOMBIA; CROSS INFECTION; DIAGNOSIS RELATED GROUP; DRUG EFFECT; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGED; ANTIMICROBIAL STEWARDSHIP; BETA-LACTAM RESISTANCE; CARBAPENEMS; CASE-CONTROL STUDIES; CEFEPIME; COLOMBIA; CROSS INFECTION; DIAGNOSIS-RELATED GROUPS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ERTAPENEM; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS;

EID: 84954306471     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2015.11.009     Document Type: Article

References (15)

1. Hernández-Gómez, C., Blanco, V.M., Motoa, G., Correa, A., Maya, J.J., de la Cadena, E., et al. Evolución de la resistencia antimicrobiana en bacilos Gram negativos en unidades de cuidado intensivo en Colombia. Biomedica. 34:Supl 1 (2014), 91–100.
2. Pacheco, R., Osorio, L., Correa, A.M., Villegas, M.V., Prevalencia de bacterias Gram negativas portadoras del gen blaKPC en hospitales de Colombia. Biomedica. 34:Supl 1 (2014), 81–90.
3. Rodríguez, E.C., Saavedra, S.Y., Leal, A.L., Álvarez, C., Olarte, N., Valderrama, A., et al. Diseminación de Klebsiella pneumoniae productoras de KPC-3 en hospitales de Bogotá durante un periodo de tres años. Biomedica. 34:Supl 1 (2014), 224–231.
4. Maldonado, N.A., Múnera, M.I., López, J.A., Sierra, P., Robledo, C., Robledo, J., et al., Grupo GERMEN. Tendencias de la resistencia a antibióticos en Medellín y en los municipios del área metropolitana entre 2007 y 2012: resultados de seis años de vigilancia. Biomedica 34 (2014), 433–446.
5. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. CLSI M100-S23. Wayne PA: CLSI; 2013.
6. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI M100-S20. Wayne PA: CLSI; 2010.
7. Salgado, P., Gilsanz, F., Maseda, E., [Therapeutic options for carbapenemase-producing Enterobacteriaceae] Spanish. Rev Esp Quimioter. 28:Suppl 1 (2015), 12–15.
8. Nordmann, P., Naas, T., Poirel, L., Global spread of carbapenemase producing Enterobacteriaceae. Emerg Infect Dis. 17 (2011), 1791–1798.
9. Kaye, K.S., Engemann, J.J., Fraimow, H.S., Abrutyn, E., Pathogens resistant to antimicrobial agents: Epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am. 18 (2004), 467–511.
10. Patel, G., Huprikar, S., Factor, S.H., Jenkins, S.G., Calfee, D.P., Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 29 (2008), 1099–1106.
11. Hyle, E.P., Ferraro, M.J., Silver, M., Lee, H., Hooper, D.C., Ertapenem resistant Enterobacteriaceae: Risk factors for acquisition and outcomes. Infect Control Hosp Epidemiol. 31 (2010), 1242–1249.
12. Liu, S.W., Chang, H.J., Chia, J.H., Kuo, A.J., Wu, T.L., Lee, M.H., Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: A matched case-control study. J Microbiol Immunol Infect. 45 (2012), 113–119.
13. Poirel, L., Pitout, J.D., Nordmann, P., Carbapenemases: Molecular diversity and clinical consequences. Future Microbiol. 2 (2007), 501–512.
14. Doumith, M., Ellington, M.J., Livermore, D.M., Woodford, N., Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother. 63 (2009), 659–667.
15. Carvalhaes, C.G., Picão, R.C., Nicoletti, A.G., Xavier, D.E., Gales, A.C., Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: Be aware of false positive results. J Antimicrob Chemother. 65 (2010), 249–251.